Expansion in International Market PPD has recently expanded its clinical research facilities to Suzhou, China, signaling a growth opportunity in the Asian market for pharmaceutical development and clinical trials services.

Increased Headcount and Laboratory Footprint With a substantial increase in headcount and nearly doubling its laboratory footprint in northern Kentucky, PPD is poised for potential sales growth in providing clinical research and drug development services to a larger volume of clients.

Strategic Partnerships for Diverse Trials By partnering with organizations like the National Minority Quality Forum, PPD is actively engaging in bringing clinical research to historically underserved patient populations. This opens up sales opportunities for conducting diverse and inclusive clinical trials.

Acquisitions for Industry Expertise Through strategic acquisitions like X-Chem and ScienceMedia, PPD has enriched its expertise in clinical trials and digital training solutions. This positions the company well to offer a wide range of services to potential clients, leading to sales growth.

Acquisition by Thermo Fisher Being acquired by Thermo Fisher Scientific for $17.4 billion has increased PPD's financial stability and market presence. Leveraging Thermo Fisher's vast resources and network, PPD can explore new sales opportunities in the global market.